Urologic Oncologist & Clinical Investigator @sloan_kettering focused on bladder cancer, prostate cancer, and clinical trials. Lucky husband & father
Dec 5, 2020 • 10 tweets • 8 min read
@TheWonkologist: All great & valid points, IMHO we as a #bladdercancer community are just so desperate for an alternative to cystectomy & @FDAOncology already set the bar so low with approval of Pembro in this space that Adstiladrin will almost certainly be FDA approved 1/n
Hopefully, patients declining RC still preferentially go on trials, but with urologists more comfortable managing urinary AEs over IO AEs, Adstiladrin will likely get a higher market share over Pembro (but Gem, GemDoce, MMC might still be used more than both) 2/n
